A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. - Kratochvil S; McKay PF; Kopycinski JT; Bishop C; Hayes PJ; Muir L; Pinder CL; Cizmeci D; King D; Aldon Y; Wines BD; Hogarth PM; et al. (Frontiers in immunology, 2017)